the pathogenesis of inflammatory dermatologic disorders and rationale for targeted biologic therapy
Published 3 months ago • 263 plays • Length 2:18:22Download video MP4
Download video MP3
Similar videos
-
57:06
using biologics to manage moderate to severe atopic dermatitis
-
25:09
targeted biologic therapy for pediatric and adult patients with moderate to severe ad
-
24:38
uncontrolled, moderate to severe asthma: identifying eligible patients for targeted biologic therapy
-
36:19
leveraging the power of targeted biologic therapy in severe asthma: do you know how and for whom?
-
39:56
advances in the management of allergic and inflammatory diseases
-
55:30
effective management approaches for atopic dermatitis across the age and disease spectrum
-
20:45
episode 2: which patients should receivetargeted biologic therapy and when?
-
49:39
advances in endometrial carcinoma treatment: the power of immunotherapy and other emerging regimens
-
29:01
addressing the global burden of atopic dermatitis: improving diagnosis, treatment, and patient care
-
32:26
targeting the burden of moderate to severe psoriasis
-
55:24
updates in eosinophilic esophagitis: underlying mechanisms and novel targeted therapy
-
1:30:31
early recognition and emerging targeted therapies in eosinophilic esophagitis
-
31:42
expert insights on the rationale for targeting epithelial alarmins in severe asthma
-
1:01:19
expert insights from around the globe on tailoring treatment for patients with atopic dermatitis
-
25:48
expert insights on when to use targeted biologic therapy for patients with eosinophilic esophagitis
-
59:53
recognition and management of egpa: a multidisciplinary approach to individualizing treatment
-
33:16
easing the burden of hes: an exploration of the role of targeted therapy to improve patient outcomes
-
1:16:25
rcc masterclass and clinical consult: novel immune and targeted therapies
-
24:42
paradoxical safety signals from biologics